<b>Conclusion:</b> This study demonstrates that METTL3/14-mediated <i>N</i> <sup>6</sup>-methyladenosine modification is a key upstream mechanism leading to GPx3 down-regulation in CRC. Here, METTL3 is linked to colorectal carcinoma.